Literature DB >> 35143209

Modulating the Influenza A Virus-Target Membrane Fusion Interface With Synthetic DNA-Lipid Receptors.

Elizabeth R Webster1, Katherine N Liu1, Robert J Rawle1, Steven G Boxer1.   

Abstract

Influenza A virus (IAV) binds to sialylated glycans on the cell membrane before endocytosis and fusion. Cell-surface glycans are highly heterogeneous in length and glycosylation density, which leads to variations in the distance and rigidity with which IAV is held away from the cell membrane. To gain mechanistic insight into how receptor length and rigidity impact the mechanism of IAV entry, we employed synthetic DNA-lipids as highly tunable surrogate receptors. We tethered IAV to target membranes with a panel of DNA-lipids to investigate the effects of the distance and tether flexibility between virions and target membranes on the kinetics of IAV binding and fusion. Tether length and the presence of a flexible linker led to higher rates of IAV binding, while the efficiencies of lipid and content mixing were typically lower for longer and more rigid DNA tethers. For all DNA tether modifications, we found that the rates of IAV lipid and content mixing were unchanged. These results suggest that variations in the interface between IAV and a target membrane do not significantly impact the rate-limiting step of fusion or the low-pH-triggered engagement of viral fusion peptides with the target membrane. However, our results imply that the flexibility of the viral receptor is important for ensuring that hemifusion events are able to successfully proceed to pore formation.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35143209      PMCID: PMC9038422          DOI: 10.1021/acs.langmuir.1c03247

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   4.331


  38 in total

1.  Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography.

Authors:  N K Sauter; J E Hanson; G D Glick; J H Brown; R L Crowther; S J Park; J J Skehel; D C Wiley
Journal:  Biochemistry       Date:  1992-10-13       Impact factor: 3.162

2.  Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity.

Authors:  Alex L Lai; Heather Park; Judith M White; Lukas K Tamm
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

3.  Kinetics of DNA-mediated docking reactions between vesicles tethered to supported lipid bilayers.

Authors:  Yee-Hung M Chan; Peter Lenz; Steven G Boxer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

4.  Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion.

Authors:  Yinling Li; Xing Han; Alex L Lai; John H Bushweller; David S Cafiso; Lukas K Tamm
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates.

Authors:  R J Connor; Y Kawaoka; R G Webster; J C Paulson
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

6.  Individual vesicle fusion events mediated by lipid-anchored DNA.

Authors:  Bettina van Lengerich; Robert J Rawle; Poul Martin Bendix; Steven G Boxer
Journal:  Biophys J       Date:  2013-07-16       Impact factor: 4.033

7.  The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation.

Authors:  L V Chernomordik; V A Frolov; E Leikina; P Bronk; J Zimmerberg
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

8.  Cholesterol enhances influenza binding avidity by controlling nanoscale receptor clustering.

Authors:  I N Goronzy; R J Rawle; S G Boxer; P M Kasson
Journal:  Chem Sci       Date:  2018-01-24       Impact factor: 9.825

9.  An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion.

Authors:  Lucie Fénéant; Katarzyna M Szymańska-de Wijs; Elizabeth A Nelson; Judith M White
Journal:  PLoS One       Date:  2019-07-05       Impact factor: 3.240

View more
  1 in total

Review 1.  Recent Developments in Single-Virus Fusion Assay.

Authors:  Sourav Haldar
Journal:  J Membr Biol       Date:  2022-09-29       Impact factor: 2.426

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.